In her role, Queen will work on ACI’s Topical Antiseptics Program, which is a multi-year research effort to demonstrate the safety and efficacy of beneficial consumer and health care antiseptic products. The research is aimed at addressing data gaps identified by the U.S. Food and Drug Administration (FDA).
Queen joins ACI from the FDA, where she was a senior staff fellow in the Center for Drug Evaluation and Research performing CMC (Chemistry, Manufacturing and Controls) biologic drug review.
Previously she served as a commissioner’s fellow for the FDA Office of Regulatory Affairs and as a technical microbiologist for Noblis. She additionally served as an adjunct faculty lecturer at Chapman University and microbiology instructor at the Howard University School of Pharmacy.
“Ashley joins ACI with extensive knowledge as an accomplished microbiologist, having worked in government, nonprofit and academic settings,” said Dr. James Kim, ACI vice president, science and regulatory affairs. “Initially, she will focus on ACI’s Topical Antiseptics Program. Down the line, she will also support potential future projects on the microbiome and probiotic cleaning.”
Queen graduated Coppin State University with a B.S. in biology and a minor in chemistry, and she has a Ph.D. in microbiology from Howard University.